Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis

BACKGROUND AND PURPOSE: Delayed-release dimethyl fumarate (DMF, also known as gastro-resistant DMF), demonstrated efficacy and safety in relapsing−remitting multiple sclerosis in the 2-year, randomized, placebo-controlled, phase 3 DEFINE and CONFIRM trials. A post hoc analysis of integrated data fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappos, L, Giovannoni, G, Gold, R, Phillips, J T, Arnold, D L, Hotermans, C, Zhang, A, Viglietta, V, Fox, R J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674988/
https://www.ncbi.nlm.nih.gov/pubmed/25557371
http://dx.doi.org/10.1111/ene.12624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674988/
https://www.ncbi.nlm.nih.gov/pubmed/25557371
http://dx.doi.org/10.1111/ene.12624

Ejemplares similares